NCT06625372View on ClinicalTrials.gov

Comparison of Intralipid With SMOF Lipid Following HSCT

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 12, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
LeukemiaHSCT
Interventions
DIETARY_SUPPLEMENT

SMOF lipid

The SMOF lipid is given to the patient as a fat component of total parenteral nutrition.

DIETARY_SUPPLEMENT

INTRALIPIDS

The Intralipid will be given to the patient as fat component of total parenteral nutrition.

Trial Locations (1)

Unknown

RECRUITING

Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran, Tehran

All Listed Sponsors
lead

Shahid Beheshti University

OTHER

NCT06625372 - Comparison of Intralipid With SMOF Lipid Following HSCT | Biotech Hunter | Biotech Hunter